Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Parexel Completes Separation of Parexel Informatics and Medical Imaging Business
Parexel International LLCJanuary 11, 2021 GMT
Strategic move enhances value and growth for both companies
Parexel Informatics to relaunch as Calyx
BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, today announced it has completed the separation of its Parexel Informatics and Medical Imaging business. The strategic move is designed to simplify and streamline Parexel’s business strategy and customer relationships while best positioning both organizations for continued, long-term growth and success. As part of the separation, Parexel Informatics will become Calyx.
Share this article
Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging, eClinical, and Regulatory solutions provider
NOTTINGHAM, England, Jan. 11, 2021 /PRNewswire/ Calyx, a leading provider of Medical Imaging, eClinical, and Regulatory solutions and services to solve complex challenges in clinical research, today launched as an independent company following the strategic separation of the Parexel Informatics business from Parexel International.
Calyx Brand Video
With 250 new drug approvals in its history, Calyx has supported over 25,000 trials involving more than fourteen million patients. The company will continue its focus on providing innovative technology solutions and services to speed the discovery of new treatments.